Literature DB >> 6274234

Absorbable suture materials for vascular anastomoses. Tensile strength and axial pressure studies using polyglycolic acid sutures.

G Ross, C Pavlides, F Long, A Kusaba, M Perlman, T Matsumoto.   

Abstract

This study attempted to evaluate how vascular healing itself is sufficient enough to provide adequate strength to autogenous vein grafts in small arteries without the use of nonabsorbable sutures. The absorbable suture, Dexon, was used in small canine femoral vein graft anastomoses over a two-month trial period with nonabsorbable Prolene as a control. Tensile strength and resistance to axial leak were measured. Results show that Dexon had 93 per cent of the tensile strength of Prolene immediately; 76 per cent at 14 days, 111 per cent at 21 days, and 110 per cent at 30 days, and 124 per cent at 60 days as an average for all suture lines. The per cent mean resistance to leakage that Dexon had compared to Prolene for all suture lines was 102 per cent at seven days, 97 per cent at 14 days, 107 per cent at 21 days, and 97 per cent at 30 days. There is no evidence of aneurysms, suture line disruptions, dilations, or infections of any anastomoses. Our ultimate conclusion is that the integrity of small autogenous vein graft is dependent on healing rather than on the permanent strength of the suture material and that Dexon maintains vascular integrity long enough to permit this healing to occur.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274234

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  [Blood vessel wall regeneration in the use of a new monofilament, resorbable suture material for arterial anastomoses].

Authors:  T Schmitz-Rixen; S Horsch; B Klein; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1984

2.  Results of an observational study in carotid surgery using absorbable suture material.

Authors:  Marko Aleksic; Jan Uedelhoven; Vladimir Matoussevitch; Thomas Luebke; Salvatore Tomagra; Barbara Krug; Jan Brunkwall
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

3.  BAD sensitizes breast cancer cells to docetaxel with increased mitotic arrest and necroptosis.

Authors:  Jasdeep Mann; Ning Yang; Rachel Montpetit; Raven Kirschenman; Hélène Lemieux; Ing Swie Goping
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.